Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 10/20 | 0.68 |
| ▸ | USP2 | O75604 | 9/20 | 0.68 |
| ▸ | MEN1 | O00255 | 9/20 | 0.68 |
| ▸ | KEAP1 | Q14145 | 6/20 | 0.68 |
| ▸ | NFE2L2 | Q16236 | 6/20 | 0.68 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.68 |
| ▸ | MAPT | P10636 | 6/20 | 0.62 |
| ▸ | RECQL | P46063 | 4/20 | 0.62 |
| ▸ | HTT | P42858 | 3/20 | 0.62 |
| ▸ | RAB9A | P51151 | 1/20 | 0.62 |
| ▸ | RGS12 | O14924 | 3/20 | 0.59 |
| ▸ | ATM | Q13315 | 2/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.57 |
| ▸ | LMNA | P02545 | 3/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.53 |
| ▸ | THRB | P10828 | 2/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29385571 | 1.00 | KMT2A (0.68) | KMT2AUSP2MEN1KEAP1NFE2L2 | |
| SCHEMBL12203015 | 0.88 | SMN1; SMN2 (0.59) | KMT2AUSP2MEN1KEAP1NFE2L2 | |
| SCHEMBL15893573 | 0.81 | ESR1 (0.56) | KMT2AMEN1L3MBTL1MAPTSMN1; SMN2 | |
| SCHEMBL9006319 | 0.80 | ALDH1A1 (0.53) | KMT2AUSP2MEN1KEAP1NFE2L2 | |
| SCHEMBL16449728 | 0.80 | KMT2A (0.82) | KMT2AUSP2MEN1KEAP1NFE2L2 | |
| SCHEMBL13428204 | 0.79 | CLTC (0.47) | KMT2AUSP2MEN1KEAP1NFE2L2 | |
| SCHEMBL28665183 | 0.78 | ESR1 (0.56) | KMT2AMEN1L3MBTL1MAPTSMN1; SMN2 | |
| SCHEMBL14004108 | 0.77 | KMT2A (0.54) | KMT2AUSP2MEN1KEAP1NFE2L2 | |
| SCHEMBL10662487 | 0.75 | ALDH1A1 (0.67) | KMT2AMEN1MAPTRAB9ASMN1; SMN2 | |
| SCHEMBL9006270 | 0.74 | KMT2A (1.00) | KMT2AUSP2MEN1KEAP1NFE2L2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5413333-A | Colored adhesive for tennis ball seams and a tennis ball seam containing the same | GENCORP INC. (US) | 1995-05-09 | — | — | US | claimed |
| US-20260048528-A1 | OPTICAL ABSORBING THERMOPLASTIC POLYMER PARTICLES AND METHODS OF PRODUCTION AND USES THEREOF | XEROX CORPORATION (US) | 2026-02-19 | — | — | US | disclosed |
| US-20230373130-A1 | OPTICAL ABSORBING THERMOPLASTIC POLYMER PARTICLES AND METHODS OF PRODUCTION AND USES THEREOF | XEROX CORPORATION (US) | 2023-11-23 | — | — | US | disclosed |
| US-11801617-B2 | Optical absorbing thermoplastic polymer particles and methods of production and uses thereof | XEROX CORPORATION (US) | 2023-10-31 | — | — | US | disclosed |
| US-20210069935-A1 | OPTICAL ABSORBING THERMOPLASTIC POLYMER PARTICLES AND METHODS OF PRODUCTION AND USES THEREOF | XEROX CORPORATION (US) | 2021-03-11 | — | — | US | disclosed |
| EP-3789429-A1 | OPTICAL ABSORBING THERMOPLASTIC POLYMER PARTICLES AND METHODS OF PRODUCTION AND USES THEREOF | Xerox Corporation (US) | 2021-03-10 | — | — | EP | disclosed |
| CN-112457504-A | Light absorbing thermoplastic polymer particles and methods of making and using the same | 施乐公司 | 2021-03-09 | — | — | CN | disclosed |
| CN-108912842-B | Liquid crystal printing ink for multiple anti-counterfeiting, preparation method and application | 北京化工大学 | 2020-05-01 | — | — | CN | disclosed |
| US-20190230766-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | FUJI XEROX CO., LTD. (JP) | 2019-07-25 | — | — | US | disclosed |
| US-8936858-B2 | Organic electroluminescent element and display | FUJI XEROX CO., LTD. (JP) | 2015-01-20 | — | — | US | disclosed |
| US-7183009-B2 | Organic electroluminescent element | FUJI XEROX CO., LTD. (JP) | 2007-02-27 | — | — | US | disclosed |
| EP-0956851-B1 | Use of nanotopes in cosmetic products | CIBA SC HOLDING AG (CH) | 2006-03-08 | — | — | EP | disclosed |
| US-7008638-B2 | Use of nanodispersions in cosmetic end formulations | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2006-03-07 | — | — | US | disclosed |
| US-20050191330-A1 | Easily prepared carrier systems for wide range of active agents and oil soluble dyes; homogeneous ethanol and water clear liquid containing phospholipid, endcapped polyoxyethylene coemulsifier and lipophilic triglyceride; wide pH range | CIBA SPECIALTY CHEMICALS CORP. | 2005-09-01 | — | — | US | disclosed |
| US-20030068347-A1 | Use of microbially encapsulated meterials in cosmetic end formulations | CIBA SPECIALTY CHEMICALS CORP. | 2003-04-10 | — | — | US | disclosed |
| EP-1246602-A2 | USE OF MICROBIALLY ENCAPSULATED MATERIALS IN COSMETIC END FORMULATIONS | Ciba SC Holding AG (CH) | 2002-10-09 | — | — | EP | disclosed |
| US-20020106390-A1 | Use of nanodispersions in cosmetic end formulations | HUGLIN DIETMAR (DE) | 2002-08-08 | — | — | US | disclosed |
| WO-2001051013-A2 | USE OF MICROBIALLY ENCAPSULATED MATERIALS IN COSMETIC END FORMULATIONS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2001-07-19 | — | — | WO | disclosed |
| EP-0956851-A1 | Use of nanotopes in cosmetic products | Ciba SC Holding AG (CH) | 1999-11-17 | — | — | EP | disclosed |
| US-5413333-A | Colored adhesive for tennis ball seams and a tennis ball seam containing the same | GENCORP INC. (US) | 1995-05-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260048528-A1 | OPTICAL ABSORBING THERMOPLASTIC POLYMER PARTICLES AND METHODS OF PRODUCTION AND USES THEREOF | SPOP, RAB5IF, CETP | KMT2A 3342/4885USP2 1775/4885MEN1 3250/4885 |
| US-20050191330-A1 | Easily prepared carrier systems for wide range of active agents and oil soluble dyes; homogeneous ethanol and water clear liquid containing phospholipid, endcapped polyoxyethylene coemulsifier and lipophilic triglyceride; wide pH range | LIPA, CETP, LIPC | KMT2A 3899/4885USP2 2490/4885MEN1 3461/4885 |
| US-20030068347-A1 | Use of microbially encapsulated meterials in cosmetic end formulations | CUTA, MGLL, TMEM205 | KMT2A 3363/4885USP2 1796/4885MEN1 37/4885 |
| US-20020106390-A1 | Use of nanodispersions in cosmetic end formulations | NPC1L1, LIPA, CUTA | KMT2A 4592/4885USP2 2066/4885MEN1 3640/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.